Nimodipin (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nimodipin" in Turkish language version.

refsWebsite

Global rank Turkish rank

8nih.gov

4^th place

11^th place

7doi.org

2^nd place

4^th place

6web.archive.org

1^st place

3fda.gov

447^th place

858^th place

2archive.org

6^th place

1espacenet.com

800^th place

3,818^th place

1books.google.com

3^rd place

5^th place

1chinaphar.com

low place

archive.org (Global: 6^th place; Turkish: 6^th place)

"Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage". N. Engl. J. Med. 308 (11): 619-24. March 1983. doi:10.1056/NEJM198303173081103. PMID 6338383. KB1 bakım: göster-yazarlar (link)
"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia". N. Engl. J. Med. 348 (4): 304-11. January 2003. doi:10.1056/NEJMoa021180. PMID 12540643.

books.google.com (Global: 3^rd place; Turkish: 5^th place)

Analogue-based Drug Discovery. John Wiley & Sons. 2006. s. 464. ISBN 9783527607495. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ağustos 2021.

chinaphar.com (Global: low place; Turkish: low place)

"Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes" (PDF). Acta Pharmacol. Sin. 21 (8): 690-4. August 2000. PMID 11501176. 8 Temmuz 2011 tarihinde kaynağından arşivlendi (PDF)29 Ağustos 2021.

doi.org (Global: 2^nd place; Turkish: 4^th place)

"Cerebral vasospasm after subarachnoid hemorrhage". Curr Opin Crit Care. 9 (2): 113-9. April 2003. doi:10.1097/00075198-200304000-00006. PMID 12657973.
"Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage". N. Engl. J. Med. 308 (11): 619-24. March 1983. doi:10.1056/NEJM198303173081103. PMID 6338383. KB1 bakım: göster-yazarlar (link)
"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia". N. Engl. J. Med. 348 (4): 304-11. January 2003. doi:10.1056/NEJMoa021180. PMID 12540643.
"Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review". Lancet Neurol. 5 (12): 1029-32. December 2006. doi:10.1016/S1474-4422(06)70582-8. PMID 17110283.
"Response to nimodipine in ultradian bipolar cycling after amygdalohippocampectomy". J Clin Psychopharmacol. 32 (1): 146-8. February 2012. doi:10.1097/JCP.0b013e31823f9116. PMID 22217956.
"Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients". Br J Clin Pharmacol. 32 (3): 335-40. September 1991. doi:10.1111/j.1365-2125.1991.tb03908.x. PMC 1368527 . PMID 1777370.
"Is there a new dawn for selective mineralocorticoid receptor antagonism?". Curr. Opin. Nephrol. Hypertens. 23 (5): 456-61. September 2014. doi:10.1097/MNH.0000000000000051. PMC 4248353 . PMID 24992570.

espacenet.com (Global: 800^th place; Turkish: 3,818^th place)

worldwide.espacenet.com

"New molecular entity with antihypertensive properties". UK Patent Office / EspaceNet Patent Search. British patent 1,358,951: Patent Office of the United Kingdom. 10 Nisan 1971. s. GB1358951. 12 Kasım 2020 tarihinde kaynağından (Patent (Post-Approval)) arşivlendi. Erişim tarihi: 11 Nisan 2019. Priority date: 1971-04-10 (...) Date issued: 1974-07-03

fda.gov (Global: 447^th place; Turkish: 858^th place)

accessdata.fda.gov

"US FDA NDA 018869". Drugs@FDA.gov Approved Drugs. Food and Drug Administration of the United States (FDA). 28 Aralık 1988. 30 Kasım 2017 tarihinde kaynağından (New drug approval from the US FDA) arşivlendi. Erişim tarihi: 11 Nisan 2019. Nimodipine (...) approved for the treatment of high blood pressure (...)
"FDA approved Labeling text. Nimotop (nimodipine) Capsules For Oral Use" (PDF). Food and Drug Administration. December 2005. 15 Mart 2010 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 21 Temmuz 2009.

fda.gov

"Information for Healthcare Professionals: Nimodipine (marketed as Nimotop)". Food and Drug Administration. 22 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Temmuz 2009.

nih.gov (Global: 4^th place; Turkish: 11^th place)

ncbi.nlm.nih.gov

"Cerebral vasospasm after subarachnoid hemorrhage". Curr Opin Crit Care. 9 (2): 113-9. April 2003. doi:10.1097/00075198-200304000-00006. PMID 12657973.
"Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage". N. Engl. J. Med. 308 (11): 619-24. March 1983. doi:10.1056/NEJM198303173081103. PMID 6338383. KB1 bakım: göster-yazarlar (link)
"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia". N. Engl. J. Med. 348 (4): 304-11. January 2003. doi:10.1056/NEJMoa021180. PMID 12540643.
"Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review". Lancet Neurol. 5 (12): 1029-32. December 2006. doi:10.1016/S1474-4422(06)70582-8. PMID 17110283.
"Response to nimodipine in ultradian bipolar cycling after amygdalohippocampectomy". J Clin Psychopharmacol. 32 (1): 146-8. February 2012. doi:10.1097/JCP.0b013e31823f9116. PMID 22217956.
"Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients". Br J Clin Pharmacol. 32 (3): 335-40. September 1991. doi:10.1111/j.1365-2125.1991.tb03908.x. PMC 1368527 . PMID 1777370.
"Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes" (PDF). Acta Pharmacol. Sin. 21 (8): 690-4. August 2000. PMID 11501176. 8 Temmuz 2011 tarihinde kaynağından arşivlendi (PDF)29 Ağustos 2021.
"Is there a new dawn for selective mineralocorticoid receptor antagonism?". Curr. Opin. Nephrol. Hypertens. 23 (5): 456-61. September 2014. doi:10.1097/MNH.0000000000000051. PMC 4248353 . PMID 24992570.

web.archive.org (Global: 1^st place; Turkish: 1^st place)

"New molecular entity with antihypertensive properties". UK Patent Office / EspaceNet Patent Search. British patent 1,358,951: Patent Office of the United Kingdom. 10 Nisan 1971. s. GB1358951. 12 Kasım 2020 tarihinde kaynağından (Patent (Post-Approval)) arşivlendi. Erişim tarihi: 11 Nisan 2019. Priority date: 1971-04-10 (...) Date issued: 1974-07-03
"US FDA NDA 018869". Drugs@FDA.gov Approved Drugs. Food and Drug Administration of the United States (FDA). 28 Aralık 1988. 30 Kasım 2017 tarihinde kaynağından (New drug approval from the US FDA) arşivlendi. Erişim tarihi: 11 Nisan 2019. Nimodipine (...) approved for the treatment of high blood pressure (...)
Analogue-based Drug Discovery. John Wiley & Sons. 2006. s. 464. ISBN 9783527607495. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ağustos 2021.
"FDA approved Labeling text. Nimotop (nimodipine) Capsules For Oral Use" (PDF). Food and Drug Administration. December 2005. 15 Mart 2010 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 21 Temmuz 2009.
"Information for Healthcare Professionals: Nimodipine (marketed as Nimotop)". Food and Drug Administration. 22 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Temmuz 2009.
"Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes" (PDF). Acta Pharmacol. Sin. 21 (8): 690-4. August 2000. PMID 11501176. 8 Temmuz 2011 tarihinde kaynağından arşivlendi (PDF)29 Ağustos 2021.

Nimodipin (Turkish Wikipedia)

archive.org (Global: 6th place; Turkish: 6th place)

books.google.com (Global: 3rd place; Turkish: 5th place)